Robert F Storey

Author PubWeight™ 12.28^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial.	Eur Heart J	2014	1.51
2	Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.	Eur Heart J	2015	1.51
3	Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes.	Heart	2014	1.46
4	Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.	Eur Heart J	2015	0.90
5	Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.	Eur Heart J	2015	0.86
6	Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis.	Eur Heart J	2017	0.83
7	Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study.	Eur Heart J	2015	0.80
8	Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.	Clin Chem	2016	0.80
9	Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.	Heart	2016	0.79
10	Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.	Eur J Prev Cardiol	2014	0.79
11	Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial.	Am Heart J	2015	0.77
12	Dyspnoea management in acute coronary syndrome patients treated with ticagrelor.	Eur Heart J Acute Cardiovasc Care	2014	0.76
13	The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial.	Eur Heart J	2014	0.76
14	Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr.	Am Heart J	2015	0.75
15	Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes.	Am Heart J	2017	0.75
16	Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sex.	Am J Med	2015	0.75